Scientific Sessions 2025  /  Advances in the Development of Therapeutic Targets in the Platelet for Prevention of Thrombosis  /  Targeting protein disulfide isomerase (PDI) to prevent thrombosis
Logo

American Heart Association

  15
  0

Final ID:

Targeting protein disulfide isomerase (PDI) to prevent thrombosis

  • Du, Xiaoping  ( UNIVERSITY OF ILLINOIS AT CHIC , Chicago , Illinois , United States )
  • Flaumenhaft, Robert  ( BIDMC, Harvard Medical School , Boston , Massachusetts , United States )
    • Author Disclosures:
    Xiaoping Du: DO have relevant financial relationships ; Individual Stocks/Stock Options:Pfizer:Active (exists now) ; Individual Stocks/Stock Options:NWBO:Active (exists now) ; Individual Stocks/Stock Options:Organon:Active (exists now) ; Individual Stocks/Stock Options:Viatris:Active (exists now) ; Individual Stocks/Stock Options:Merck:Active (exists now) ; Individual Stocks/Stock Options:GE Healthcare:Active (exists now) ; Individual Stocks/Stock Options:Abbvie:Active (exists now) ; Individual Stocks/Stock Options:Abbott:Active (exists now) | Robert Flaumenhaft: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Advances in the Development of Therapeutic Targets in the Platelet for Prevention of Thrombosis

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Oxylipin regulators of platelet function and thrombosis

Patrignani Paola, Hwa John

The past, present, and future of antiplatelet therapy and prevention of thrombosis

Holinstat Michael, Bergmeier Wolfgang

You have to be authorized to contact abstract author. Please, Login
Not Available